Case Reports
A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer
- PMID: 6694625
Item in Clipboard
Case Reports
A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer
Med J Aust.
.
Abstract
Flutamide, a new non-steroidal antiandrogenic agent, was administered in the treatment of five assessable patients with advanced carcinoma of the prostate. Two patients showed significant clinical benefit, one showed a reduction in his requirement for analgesia and two failed to benefit; side-effects were minimal. These results indicate the need for a controlled clinical trial of flutamide in patients with prostatic cancer.
Similar articles
-
The use of flutamide as monotherapy in the treatment of advanced prostate cancer.Prog Clin Biol Res. 1989;303:117-21. Prog Clin Biol Res. 1989. PMID: 2674980 Review. No abstract available.
-
'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.Prog Clin Biol Res. 1989;303:145-51. Prog Clin Biol Res. 1989. PMID: 2528737 Clinical Trial.
-
Treatment of advanced prostatic cancer with flutamide.Pa Med. 1979 Sep;82(9):29-31. Pa Med. 1979. PMID: 386212 Clinical Trial. No abstract available.
-
Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.Int J Urol. 2007 Mar;14(3):264-7. doi: 10.1111/j.1442-2042.2007.01681.x. Int J Urol. 2007. PMID: 17430272
-
Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.Prog Clin Biol Res. 1989;303:161-7. Prog Clin Biol Res. 1989. PMID: 2674982 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical